Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus in Saudi Arabia: A Post Authorization Safety Study

被引：0
|
作者：
Abdullah M. Alguwaihes
机构：
[1] King Saud University,Department of Internal Medicine, College of Medicine
来源：
Diabetes Therapy | 2021年 / 12卷
关键词：
Dapagliflozin; Diabetic ketoacidosis; HbA1c; Post-authorization safety study; Saudi Arabia; SGLT2 inhibitor; T2DM; Urinary tract infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1979 / 1992
页数：13
相关论文
共 50 条
  • [1] Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus in Saudi Arabia: A Post Authorization Safety Study
    Alguwaihes, Abdullah M.
    DIABETES THERAPY, 2021, 12 (07) : 1979 - 1992
  • [2] Safety and efficacy of Dapagliflozin type 2 diabetes mellitus patients during fasting
    Fatima, N.
    Baloch, A. Ali
    Kiran, Z.
    Shabbir, K. U.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 209
  • [3] Efficacy and Safety of Dapagliflozin as Monotherapy for Type 2 Diabetes Mellitus in Japanese Patients
    Kaku, Kohei
    Inoue, Satoshi
    Matsuoka, Osamu
    Kiyosue, Arihiro
    Azuma, Haruna
    Hayashi, Nobuya
    Tokudome, Takuto
    Langkilde, Anna Maria
    Parikh, Shamik
    DIABETES, 2012, 61 : A260 - A260
  • [4] Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus in China: Results from the DONATE Study
    Guo, Lixin
    Wang, Jing
    Li, Li
    Yuan, Lin
    Chen, Sheng
    Wang, Hui
    Li, Tonghuan
    Qi, Lin
    Yang, Hong
    DIABETES, 2022, 71
  • [5] Safety of dapagliflozin in clinical trials for type 2 diabetes mellitus
    Johnsson, K.
    Ptaszynska, A.
    Apanovitch, A.
    Sugg, J. E.
    Parikh, S. J.
    List, J. F.
    DIABETOLOGIA, 2012, 55 : S304 - S304
  • [6] SAFETY OF DAPAGLIFLOZIN IN CLINICAL TRIALS FOR TYPE 2 DIABETES MELLITUS
    Ptaszynska, Agata
    Johnsson, Kristina
    Apanovitch, Anne Marie
    Sugg, Jennifer
    Parikh, Shamik
    List, James
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 50 - 50
  • [7] Efficacy and Safety of Dapagliflozin for Type 2 Diabetes Mellitus Patients With a History of Cardiovascular Disease
    Leiter, Lawrence A.
    Cefalu, William T.
    Debruin, Tjerk W.
    Gausenilsson, Ingrid
    Sugg, Jennifer
    Parikh, Shamik J.
    DIABETES, 2012, 61 : A287 - A287
  • [8] Efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus and concomitant heart failure
    Kosiborod, M.
    Gause-Nilsson, I.
    Sonesson, C.
    Johnsson, E.
    DIABETOLOGIA, 2015, 58 : S368 - S368
  • [9] Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India
    Varshney, Amit
    Rawat, Ramakant
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (08):
  • [10] The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus
    Michelle L. O’Donoghue
    Eri T. Kato
    Ofri Mosenzon
    Sabina A. Murphy
    Avivit Cahn
    Marisol Herrera
    Tsvetalina Tankova
    Alena Šmahelová
    Piera Merlini
    Ingrid Gause-Nilsson
    Anna Maria Langkilde
    Darren K. McGuire
    John P. H. Wilding
    Larry A. Leiter
    Deepak L. Bhatt
    Itamar Raz
    Marc S. Sabatine
    Stephen D. Wiviott
    Diabetologia, 2021, 64 : 1226 - 1234
12345